Group 1 - Several listed companies, including *ST Hengli and Aucma, have postponed the disclosure of their 2024 annual reports and 2025 Q1 reports due to delays in audit and preparation work [1] - *ST Hengli has announced a delay in its report disclosure from April 28, 2025, to April 30, 2025, while Aucma's disclosure has been postponed from April 26, 2025, to April 30, 2025 [1] - Both companies have indicated potential risks, with *ST Hengli facing a possible delisting if its 2024 revenue falls below 300 million yuan, and Aucma correcting its previous profit forecast from a profit to a loss of 45 million to 50 million yuan [1][2] Group 2 - *ST Hengli's performance forecast indicates a revenue of 300 million to 350 million yuan for 2024, with total losses expected to be between 35 million and 45 million yuan [2] - The company has highlighted significant discrepancies with its auditors regarding revenue recognition, which could impact its final revenue figures [3] - Additionally, *ST Hengli is facing multiple lawsuits, resulting in the freezing of some bank accounts, which has negatively affected its operational activities [4] Group 3 - Aucma has unexpectedly revised its profit forecast, now expecting a loss of 45 million to 50 million yuan for 2024, with a further loss of 72 million to 78 million yuan when excluding non-recurring items [5] - The revision is attributed to incomplete audit assessments during the initial forecast, leading to the identification of impairment risks and the need for credit impairment provisions [5] - Aucma's declining performance is linked to insufficient domestic consumer demand and increased competition, alongside challenges faced by its new overseas investments [6]